SEARCH

SEARCH BY CITATION

References

  • Arai T., Miklossy J., Klegeris A., Guo J. P. and McGeer P. L. (2006) Thrombin and prothrombin are expressed by neurons and glial cells and accumulate in neurofibrillary tangles in Alzheimer disease brain. J. Neuropathol. Exp. Neurol. 65, 1925.
  • Ashby E. L., Kehoe P. G. and Love S. (2011) Kallikrein-related peptidase 6 in Alzheimer's disease and vascular dementia. Brain Res. 1363, 110.
  • Basso D. M., Fisher L. C., Anderson A. J., Jakeman L. B., McTigue D. M. and Popovich P. G. (2006) Basso mouse scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains. J. Neurotrauma 23, 635659.
  • Benavente F., Pinto C., Parada M., Henriquez J. P. and Osses N. (2012) Bone morphogenetic protein 2 inhibits neurite outgrowth of motor neuron-like NSC-34 cells and up-regulates its type II receptor. J. Neurochem. 122, 594604.
  • Bennur S., Shankaranarayana Rao B. S., Pawlak R., Strickland S., McEwen B. S. and Chattarji S. (2007) Stress-induced spine loss in the medial amygdala is mediated by tissue-plasminogen activator. Neuroscience 144, 816.
  • Bernett M. J., Blaber S. I., Scarisbrick I. A., Dhanarajan P., Thompson S. M. and Blaber M. (2002) Crystal structure and biochemical characterization of human kallikrein 6 reveals that a trypsin-like kallikrein is expressed in the central nervous system. J. Biol. Chem. 277, 2456224570.
  • Biasini E., Unterberger U., Solomon I. H. et al. (2013) A mutant prion protein sensitizes neurons to glutamate-induced excitotoxicity. J. Neurosci. 33, 24082418.
  • Blaber S. I., Scarisbrick I. A., Bernett M. J., Dhanarajan P., Seavy M. A., Jin Y., Schwartz M. A., Rodriguez M. and Blaber M. (2002) Enzymatic properties of rat myelencephalon-specific protease. Biochemistry 41, 11651173.
  • Blaber S. I., Ciric B., Christophi G. P., Bernett M. J., Blaber M., Rodriguez M. and Scarisbrick I. A. (2004) Targeting kallikrein 6-proteolysis attenuates CNS inflammatory disease. FASEB J. 19, 920922.
  • Boven L. A., Vergnolle N., Henry S. D., Silva C., Imai Y., Holden J., Warren K., Hollenberg M. D. and Power C. (2003) Up-regulation of proteinase-activated receptor 1 expression in astrocytes during HIV encephalitis. J. Immunol. 170, 26382646.
  • Bridges R., Lutgen V., Lobner D. and Baker D. A. (2012) Thinking outside the cleft to understand synaptic activity: contribution of the cystine-glutamate antiporter (System xc-) to normal and pathological glutamatergic signaling. Pharmacol. Rev. 64, 780802.
  • Cashman N. R., Durham H. D., Blusztajn J. K., Oda K., Tabira T., Shaw I. T., Dahrouge S. and Antel J. P. (1992) Neuroblastoma spinal cord (NSC) hybrid cell lines resemble developing motor neurons. Dev. Dyn. 194, 209221.
  • Chen B., Friedman B., Whitney M. A. et al. (2012) Thrombin activity associated with neuronal damage during acute focal ischemia. J. Neurosci. 32, 76227631.
  • Choi S. H., Joe E. H., Kim S. U. and Jin B. K. (2003) Thrombin-induced microglial activation produces degeneration of nigral dopaminergic neurons in vivo. J. Neurosci. 23, 58775886.
  • Choi S. H., Lee D. Y., Kim S. U. and Jin B. K. (2005) Thrombin-induced oxidative stress contributes to the death of hippocampal neurons in vivo: role of microglial NADPH oxidase. J. Neurosci. 25, 40824090.
  • Christophi G. P., Isackson P. J., Blaber S. I., Blaber M., Rodriguez M. and Scarisbrick I. A. (2004) Distinct promoters regulate tissue-specific and differential expression of kallikrein 6 in CNS demyelinating disease. J. Neurochem. 91, 14391449.
  • Cisowski J., O'Callaghan K., Kuliopulos A. et al. (2011) Targeting protease-activated receptor-1 with cell-penetrating pepducins in lung cancer. Am. J. Pathol. 179, 513523.
  • Citron B. A., Smirnova I. V., Arnold P. M. and Festoff B. W. (2000) Upregulation of neurotoxic serine proteases, prothrombin, and protease- activated receptor 1 early after spinal cord injury. J. Neurotrauma 17, 11911203.
  • Contestabile A. (2002) Cerebellar granule cells as a model to study mechanisms of neuronal apoptosis or survival in vivo and in vitro. Cerebellum 1, 4155.
  • Cunningham D. D., Pulliam L. and Vaughan P. J. (1993) Protease nexin-1 and thrombin: injury-related processes in the brain. Thromb. Haemost. 70, 168171.
  • Diamandis E. P., Yousef G. M., Soosaipillai A. R. and Bunting P. (2000) Human kallikrein 6 (zyme/protease M/neurosin): a new serum biomarker of ovarian carcinoma. Clin. Biochem. 33, 579583.
  • Dihanich M., Kaser M., Reinhard E., Cunningham D. and Monard D. (1991) Prothrombin mRNA is expressed by cells of the nervous system. Neuron 6, 575581.
  • Donovan F. M., Pike C. J., Cotman C. W. and Cunningham D. D. (1997) Thrombin induces apoptosis in cultured neurons and astrocytes via a pathway requiring tyrosine kinase and RhoA activities. J. Neurosci. 17, 53165326.
  • Eggett C. J., Crosier S., Manning P., Cookson M. R., Menzies F. M., McNeil C. J. and Shaw P. J. (2000) Development and characterisation of a glutamate-sensitive motor neurone cell line. J. Neurochem. 74, 18951902.
  • Friedmann I., Yoles E. and Schwartz M. (2001) Thrombin attenuation is neuroprotective in the injured rat optic nerve. J. Neurochem. 76, 641649.
  • Fujimoto S., Katsuki H., Kume T. and Akaike A. (2006) Thrombin-induced delayed injury involves multiple and distinct signaling pathways in the cerebral cortex and the striatum in organotypic slice cultures. Neurobiol. Dis. 22, 130142.
  • Gingrich M. B. and Traynelis S. F. (2000) Serine proteases and brain damage - is there a link? Trends Neurosci. 23, 399407.
  • Gingrich M. B., Junge C. E., Lyuboslavsky P. and Traynelis S. F. (2000) Potentiation of NMDA receptor function by the serine protease thrombin. J. Neurosci. 20, 45824595.
  • Gorbacheva L. R., Storozhevykh T. P., Pinelis V. G., Ishiwata S. and Strukova S. M. (2006) Modulation of hippocampal neuron survival by thrombin and factor Xa. Biochemistry (Mosc) 71, 10821089.
  • Hamill C. E., Mannaioni G., Lyuboslavsky P., Sastre A. A. and Traynelis S. F. (2009) Protease-activated receptor 1-dependent neuronal damage involves NMDA receptor function. Exp. Neurol. 217, 136146.
  • Han K. S., Mannaioni G., Hamill C. E., Lee J., Junge C. E., Lee C. J. and Traynelis S. F. (2011) Activation of protease activated receptor 1 increases the excitability of the dentate granule neurons of hippocampus. Mol. Brain 4, 32.
  • He B. P., Wen W. and Strong M. J. (2002) Activated microglia (BV-2) facilitation of TNF-alpha-mediated motor neuron death in vitro. J. Neuroimmunol. 128, 3138.
  • Henrich-Noack P., Riek-Burchardt M., Bakdauf K., Reiser G. and Reymann K. G. (2006) Focal ischemia induces expression of protease-activated receptor1 (PAR1) and PAR3 on microglia and enhances PAR4 labeling in the penumbra. Brain Res. 1070, 232241.
  • Hermann G. E., Van Meter M. J., Rood J. C. and Rogers R. C. (2009) Proteinase-activated receptors in the nucleus of the solitary tract: evidence for glial-neural interactions in autonomic control of the stomach. J. Neurosci. 29, 92929300.
  • Himi T., Ikeda M., Yasuhara T. and Murota S. I. (2003) Oxidative neuronal death caused by glutamate uptake inhibition in cultured hippocampal neurons. J. Neurosci. Res. 71, 679688.
  • Ishida Y., Nagai A., Kobayashi S. and Kim S. U. (2006) Upregulation of protease-activated receptor-1 in astrocytes in Parkinson disease: astrocyte-mediated neuroprotection through increased levels of glutathione peroxidase. J. Neuropathol. Exp. Neurol. 65, 6677.
  • Iwata A., Maruyama M., Akagi T., Hashikawa T., Kanazawa I., Tsuji S. and Nukina N. (2003) Alpha-synuclein degradation by serine protease neurosin: implication for pathogenesis of synucleinopathies. Hum. Mol. Genet. 12, 26252635.
  • Johann S., Dahm M., Kipp M., Zahn U. and Beyer C. (2011) Regulation of choline acetyltransferase expression by 17 beta-oestradiol in NSC-34 cells and in the spinal cord. J. Neuroendocrinol. 23, 839848.
  • Joshi M. and Fehlings M. (2002a) Development and characterization of a novel, graded model of clip compressive spinal cord injury in the mouse: Part 1. Clip design, behavioral outcomes, and histopathology. J. Neurotrauma 19, 175190.
  • Joshi M. and Fehlings M. (2002b) Development and characterization of a novel, graded model of clip compressive spinal cord injury in the mouse: Part 2. Quantitative neuroanatomical assessment and analysis of the relationships between axonal tracts, residual tissue, and locomotor recovery. J. Neurotrauma 19, 191203.
  • Junge C. E., Sugawara T., Mannaioni G., Alagarsamy S., Conn P. J., Brat D. J., Chan P. H. and Traynelis S. F. (2003) The contribution of protease-activated receptor 1 to neuronal damage caused by transient focal cerebral ischemia. Proc. Natl Acad. Sci. USA 100, 1301913024.
  • Junge C. E., Lee C. J., Hubbard K. B., Ahoabin A., Olson J. J., Hepler J. R., Brat D. J. and Traynelis S. F. (2004) Protease-activated receptor-1 in human brain: localization and functional expression in astrocytes. Exp. Neurol. 1888, 94103.
  • Kasai T., Tokuda T., Yamaguchi N., Watanabe Y., Kametani F., Nakagawa M. and Mizuno T. (2008) Cleavage of normal and pathological forms of alpha-synuclein by neurosin in vitro. Neurosci. Lett. 436, 5256.
  • Kaufmann S., Desnoyers S., Ottaviano Y., Davidson N. and Poirier G. (1993) Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res. 53, 39763985.
  • Keep R. F., Xi G., Hua Y. and Hoff J. T. (2005) The deleterious or beneficial effects of different agents in intracerebral hemorrhage: think big, think small, or is hematoma size important? Stroke 36, 15941596.
  • Kondo N., Ogawa M., Wada H. and Nishikawa S. (2009) Thrombin induces rapid disassembly of claudin-5 from the tight junction of endothelial cells. Exp. Cell Res. 315, 28792887.
  • Koshimizu H., Kiyosue K., Hara T. et al. (2009) Multiple functions of precursor BDNF to CNS neurons: negative regulation of neurite growth, spine formation and cell survival. Mol. Brain 2, 27.
  • Lin C. L., Bristol L. A., Jin L., Dykes-Hoberg M., Crawford T., Clawson L. and Rothstein J. D. (1998) Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis. Neuron 20, 589602.
  • Mercer E. A., Korhonen L., Skoglosa Y., Olsson P. A., Kukkonen J. P. and Lindholm D. (2000) NAIP interacts with hippocalcin and protects neurons against calcium-induced cell death through caspase-3-dependent and -independent pathways. EMBO J. 19, 35973607.
  • Mitsui S., Okui A., Uemura H., Mizuno T., Yamada T., Yamamura Y. and Yamaguchi N. (2002) Decreased cerebrospinal fluid levels of neurosin (KLK6), an aging-related protease, as a possible new risk factor for Alzheimer's disease. Ann. N. Y. Acad. Sci. 977, 216223.
  • Murphy T. H., Schnaar R. L. and Coyle J. T. (1990) Immature cortical neurons are uniquely sensitive to glutamate toxicity by inhibition of cystine uptake. FASEB J. 4, 16241633.
  • Nicole O., Goldshmidt A., Hamill C. E., Sorensen S. D., Sastre A., Lyuboslavsky P., Hepler J. R., McKeon R. J. and Traynelis S. F. (2005) Activation of protease-activated receptor-1 triggers astrogliosis after brain injury. J. Neurosci. 25, 43194329.
  • Nishino A., Suzuki M., Ohtani H., Motohashi O., Umezawa K., Nagura H. and Yoshimoto T. (1993) Thrombin may contribute to the pathophysiology of central nervous system injury. J. Neurotrauma 10, 167179.
  • Noorbakhsh F., Vergnolle N., McArthur J. C., Silva C., Vodjgani M., Andrade-Gordon P., Hollenberg M. D. and Power C. (2005) Proteinase-activated receptor-2 induction by neuroinflammation prevents neuronal death during HIV infection. J. Immunol. 174, 73207329.
  • Ogawa K., Yamada T., Tsujioka Y. et al. (2000) Localization of a novel type trypsin-like serine protease, neurosin, in brain tissues of Alzheimer's disease and Parkinson's disease. Psychiatry Clin. Neurosci. 54, 419426.
  • Park J. K., Williams B. P., Alberta J. A. and Stiles C. D. (1999) Bipotent cortical progenitor cells process conflicting cues for neurons and glia in a hierarchical manner. J. Neurosci. 19, 1038310389.
  • Pompili E., Nori S. L., Geloso M. C., Guadagni E., Corvino V., Michetti F. and Fumagalli L. (2004) Trimethyltin-induced differential expression of PAR subtypes in reactive astrocytes of the rat hippocampus. Brain Res. Mol. Brain Res. 122, 9398.
  • Prause J., Goswami A., Katona I. et al. (2013) Altered localization, abnormal modification and loss of function of Sigma receptor-1 in amyotrophic lateral sclerosis. Hum. Mol. Genet. 22, 15811600.
  • Putnam F. (1975) The Plasma Proteins. Academic Press, New York.
  • Raimondi A., Mangolini A., Rizzardini M. et al. (2006) Cell culture models to investigate the selective vulnerability of motoneuronal mitochondria to familial ALS-linked G93ASOD1. Eur. J. Neurosci. 24, 387399.
  • Ramachandran R., Noorbakhsh F., Defea K. and Hollenberg M. D. (2012) Targeting proteinase-activated receptors: therapeutic potential and challenges. Nat. Rev. Drug Discov. 11, 6986.
  • Ratan R. R., Murphy T. H. and Baraban J. M. (1994) Macromolecular synthesis inhibitors prevent oxidative stress-induced apoptosis in embryonic cortical neurons by shunting cysteine from protein synthesis to glutathione. J. Neurosci. 14, 43854392.
  • Regan R. F. and Choi D. W. (1991) Glutamate neurotoxicity in spinal cord cell culture. Neuroscience 43, 585591.
  • Riek-Burchardt M., Striggow F., Henrich-Noack P., Reiser G. and Reymann K. G. (2002) Increase of prothrombin-mRNA after global cerebral ischemia in rats, with constant expression of protease nexin-1 and protease-activated receptors. Neurosci. Lett. 329, 181184.
  • Rossi D. J., Oshima T. and Attwell D. (2000) Glutamate release in severe brain ischaemia is mainly by reversed uptake. Nature 403, 316321.
  • Scarisbrick I. A., Towner M. D. and Isackson P. J. (1997) Nervous system specific expression of a novel serine protease: regulation in the adult rat spinal cord by excitotoxic injury. J. Neurosci. 17, 81568168.
  • Scarisbrick I. A., Asakura K., Blaber S., Blaber M., Isackson P. J., Beito T., Rodriguez M. and Windebank A. J. (2000) Preferential expression of myelencephalon specific protease by oligodendrocytes of the adult rat spinal cord white matter. Glia 30, 219230.
  • Scarisbrick I. A., Isackson P. J., Ciric B., Windebank A. J. and Rodriguez M. (2001) MSP, a trypsin-like serine protease, is abundantly expressed in the human nervous system. J. Comp. Neurol. 431, 347361.
  • Scarisbrick I. A., Blaber S. I., Lucchinetti C. F., Genain C. P., Blaber M. and Rodriguez M. (2002) Activity of a newly identified serine protease in CNS demyelination. Brain 125, 12831296.
  • Scarisbrick I. A., Blaber S. I., Tingling J. T., Rodriguez M., Blaber M. and Christophi G. P. (2006a) Potential scope of action of tissue kallikreins in CNS immune-mediated disease. J. Neuroimmunol. 178, 167176.
  • Scarisbrick I. A., Sabharwal P., Cruz H. et al. (2006b) Dynamic role of kallikrein 6 in traumatic spinal cord injury. Eur. J. Neurosci. 24, 14571469.
  • Scarisbrick I. A., Linbo R., Vandell A. G. et al. (2008) Kallikreins are associated with secondary progressive multiple sclerosis and promote neurodegeneration. Biol. Chem. 389, 739745.
  • Scarisbrick I. A., Radulovic M., Burda J. E., Larson N., Blaber S. I., Giannini C., Blaber M. and Vandell A. G. (2012a) Kallikrein 6 is a novel molecular trigger of reactive astrogliosis. Biol. Chem. 393, 355367.
  • Scarisbrick I. A., Yoon H., Panos M., Larson N., Blaber S. I., Blaber M. and Rodriguez M. (2012b) Kallikrein 6 regulates early CNS demyelination in a viral model of multiple sclerosis. Brain Pathol. 22, 709722.
  • Sevigny L. M., Zhang P., Bohm A., Lazarides K., Perides G., Covic L. and Kuliopulos A. (2011) Interdicting protease-activated receptor-2-driven inflammation with cell-penetrating pepducins. Proc. Natl Acad. Sci. USA 108, 84918496.
  • Shaw J. L. and Diamandis E. P. (2007) Distribution of 15 human kallikreins in tissues and biological fluids. Clin. Chem. 53, 14231432.
  • Smirnova I. V., Zhang S. X., Citron B. A., Arnold P. M. and Festoff B. W. (1998) Thrombin is an extracellular signal that activates intracellular death protease pathways inducing apoptosis in model motor neurons. J. Neurobiol. 36, 6480.
  • Springer J. E., Azbill R. D., Kennedy S. E., George J. and Geddes J. W. (1997) Rapid calpain I activation and cytoskeletal protein degradation following traumatic spinal cord injury: attenuation with riluzole pretreatment. J. Neurochem. 69, 15921600.
  • Striggow F., Riek M., Breder J., Henrich-Noack P., Reymann K. G. and Reiser G. (2000) The protease thrombin is an endogenous mediator of hippocampal neuroprotection against ischemia at low concentrations but causes degeneration at high concentrations. Proc. Natl Acad. Sci. USA 97, 22642269.
  • Striggow F., Riek-Burchardt M., Kiesel A., Schmidt W., Henrich-Noack P., Breder J., Krug M., Reymann K. G. and Reiser G. (2001) Four different types of protease-activated receptors are widely expressed in the brain and are up-regulated in hippocampus by severe ischemia. Eur. J. Neurosci. 14, 595608.
  • Suo Z., Wu M., Ameenuddin S., Anderson H. E., Zoloty J. E., Citron B. A., Andrade-Gordon P. and Festoff B. W. (2002) Participation of protease-activated receptor-1 in thrombin-induced microglial activation. J. Neurochem. 80, 655666.
  • Tatebe H., Watanabe Y., Kasai T., Mizuno T., Nakagawa M., Tanaka M. and Tokuda T. (2010) Extracellular neurosin degrades alpha-synuclein in cultured cells. Neurosci. Res. 67, 341346.
  • Terayama R., Bando Y., Takahashi T. and Yoshida S. (2004) Differential expression of neuropsin and protease M/neurosin in oligodendrocytes after injury to the spinal cord. Glia 48, 91101.
  • Tsirka S. E., Gualandris A., Amaral D. G. and Strickland S. (1995) Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator. Nature 377, 340344.
  • Tsirka S. E., Rogove A. D., Bugge T. H., Degan J. L. and Strickland S. (1997) An extracellular proteolytic cascade promotes neuronal degeneration in the mouse hippocampus. J. Neurosci. 15, 543552.
  • Turgeon V. L., Lloyd E. D., Wang S., Festoff B. W. and Houenou L. J. (1998) Thrombin perturbs neurite outgrowth and induces apoptotic cell death in enriched chick spinal motoneuron cultures through caspase activation. J. Neurosci. 18, 68826891.
  • Uchida A., Oka Y., Aoyama M. et al. (2004) Expression of myelencephalon-specific protease in transient middle cerebral artery occlusion model of rat brain. Brain Res. Mol. Brain Res. 126, 129136.
  • Vandell A. G., Larson N., Laxmikanthan G., Panos M., Blaber S. I., Blaber M. and Scarisbrick I. A. (2008) Protease activated receptor dependent and independent signaling by kallikreins 1 and 6 in CNS neuron and astroglial cell lines. J. Neurochem. 107, 855870.
  • Vu T. K., Wheaton V. I., Hung D. T., Charo I. and Coughlin S. R. (1991) Domains specifying thrombin-receptor interaction. Nature 353, 674677.
  • Waltereit R. and Weller M. (2003) Signaling from cAMP/PKA to MAPK and synaptic plasticity. Mol. Neurobiol. 27, 99106.
  • Wang H., Ubl J. J., Stricker R. and Reiser G. (2002) Thrombin (PAR-1)-induced proliferation in astrocytes via MAPK involves multiple signaling pathways. Am. J. Physiol. Cell Physiol. 283, C1351C1364.
  • Wells J. E., Rice T. K., Nuttall R. K., Edwards D. R., Zekki H., Rivest S. and Yong V. W. (2003) An adverse role of matrix metalloproteinase 12 after spinal cord injury in mice. J. Neurosci. 23, 1010710115.
  • Zarghooni M., Soosaipillai A., Grass L., Scorilas A., Mirazimi N. and Diamandis E. P. (2002) Decreased concentration of human kallikrein 6 in brain extracts of Alzheimer's disease patients. Clin. Biochem. 35, 225231.